Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Can VEGF reverse diabetic neuropathy in human subjects?
Aristidis Veves, George L. King
Aristidis Veves, George L. King
Published May 15, 2001
Citation Information: J Clin Invest. 2001;107(10):1215-1218. https://doi.org/10.1172/JCI13038.
View: Text | PDF
Commentary

Can VEGF reverse diabetic neuropathy in human subjects?

  • Text
  • PDF
Abstract

Authors

Aristidis Veves, George L. King

×

Total citations by year

Year: 2025 2023 2022 2021 2019 2018 2017 2016 2013 2011 2009 2008 2007 2003 Total
Citations: 1 2 2 1 1 3 2 2 1 1 2 2 2 1 23
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (23)

Title and authors Publication Year
Tissue nanotransfection-based endothelial PLCγ2-targeted epigenetic gene editing rescues perfusion and diabetic ischemic wound healing
Verma SS, Sen CK, Srivastava R, Gnyawali SC, Katiyar P, Sahi AK, Kumar M, Rustagi Y, Liu S, Pandey D, Abouhashem AS, Fehme LN, Kacar S, Mohanty SK, Faden-McCormack J, Murphy MP, Roy S, Wan J, Yoder MC, Singh K
Molecular Therapy 2025
Sudomotor dysfunction in diabetic peripheral neuropathy (DPN) and its testing modalities: A literature review
Akbar M, Wandy A, Soraya GV, Goysal Y, Lotisna M, Basri MI
Heliyon 2023
Dose and time-response effect of photobiomodulation therapy on glycemic control in type 2 diabetic patients combined or not with hypoglycemic medicine: a randomized, crossover, double-blind, sham-controlled trial
Scontri CM, de Castro Magalhães F, Damiani AP, Hamblin MR, Zamunér AR, Ferraresi C
Journal of Biophotonics 2023
Insulin enhances neurite extension and myelination of diabetic neuropathy neurons.
Pham VM, Thakor N
The Korean Journal of Pain 2022
Mechanistic investigations of diabetic ocular surface diseases.
Zhou Q, Yang L, Wang Q, Li Y, Wei C, Xie L
Frontiers in Endocrinology 2022
Insulin's actions on vascular tissues: Physiological effects and pathophysiological contributions to vascular complications of diabetes
J Fu, MG Yu, Q Li, K Park, GL King
Molecular Metabolism 2021
Efficacy of autologous bone marrow mononuclear cell transplantation therapy in patients with refractory diabetic peripheral neuropathy:
H Mao, W Wei, XL Fu, JJ Dong, XY Lyu, T Jia, Y Tang, S Zhao
Chinese Medical Journal 2019
The route of administration influences the therapeutic index of an anti-proNGF neutralizing mAb for experimental treatment of Diabetic Retinopathy
PF Barcelona, A Galan, H Nedev, Y Jian, MV Sarunic, HU Saragovi, GS Liu
PloS one 2018
Autonomic disturbances in diabetes: Assessment and anaesthetic implications
S Moningi, S Nikhar, G Ramachandran
Indian journal of anaesthesia 2018
A cardiac risk score based on sudomotor function to evaluate cardiovascular autonomic neuropathy in asymptomatic Chinese patients with diabetes mellitus
T Yuan, J Li, Y Fu, T Xu, J Li, X Wang, Y Zhou, Y Dong, W Zhao, C Hu
PloS one 2018
Preconditioning of adipose tissue-derived mesenchymal stem cells with deferoxamine increases the production of pro-angiogenic, neuroprotective and anti-inflammatory factors: Potential application in the treatment of diabetic neuropathy
C Oses, B Olivares, M Ezquer, C Acosta, P Bosch, M Donoso, P Léniz, F Ezquer, R Kirchmair
PloS one 2017
Cardiorespiratory Fitness and Cardiac Autonomic Function in Diabetes.
Röhling M, Strom A, Bönhof GJ, Roden M, Ziegler D
Current Diabetes Reports 2017
PKCδ Inhibition Normalizes Wound Healing Capacity of Diabetic Human Fibroblasts
Mogher Khamaisi, Sayaka Katagiri, Hillary Keenan, Kyoungmin Park, Yasutaka Maeda, Weier Qi, Qian Li, Thomas Thomou, Danielle Eschuk, Ana Tellechea, Aristidis Veves, Chenyu Huang, Dennis P. Orgill, Amy Wagers, George Liang King
Journal of Clinical Investigation 2016
Induction of VEGFA and Snail-1 by meningitic Escherichia coli mediates disruption of the blood-brain barrier
R Yang, W Liu, L Miao, X Yang, J Fu, B Dou, A Cai, X Zong, C Tan, H Chen, X Wang
Oncotarget 2016
Ruboxistaurin for the treatment of diabetic peripheral neuropathy: a systematic review of randomized clinical trials
D Bansal, Y Badhan, K Gudala, F Schifano
Diabetes & Metabolism Journal 2013
Painful diabetic neuropathy: an update
Sharonjeet Kaur, Promila Pandhi, Pinaki Dutta
Annals of Neurosciences 2011
Vascular endothelial growth factor gene transfer for diabetic polyneuropathy
JA Kessler
Annals of Neurology 2009
Microvascular reactivity and inflammatory cytokines in painful and painless peripheral diabetic neuropathy
J Doupis, TE Lyons, S Wu, C Gnardellis, T Dinh, A Veves
The Journal of clinical endocrinology and metabolism 2009
Mechanisms of disease: The oxidative stress theory of diabetic neuropathy
C Figueroa-Romero, M Sadidi, EL Feldman
Reviews in Endocrine and Metabolic Disorders 2008
Diabetic neuropathy: mechanisms to management
JL Edwards, AM Vincent, HT Cheng, EL Feldman
Pharmacology & Therapeutics 2008
Clinical improvement after treatment with VEGF(165) in patients with severe chronic lower limb ischaemia
A Anghel, B Mut-Vitcu, L Savu, C Marian, E Seclaman, R Iman, AM Neghina, SI Dragulescu
Genomic Medicine 2007
Induction of vascular endothelial growth factor release by transcutaneous frequency modulated neural stimulation in diabetic polyneuropathy
M Bevilacqua, LJ Dominguez, M Barrella, M Barbagallo
Journal of Endocrinological Investigation 2007
Paracrine control of vascularization and neurogenesis by neurotrophins
C Emanueli, P Schratzberger, R Kirchmair, P Madeddu
British Journal of Pharmacology 2003

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts